BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1684636)

  • 1. Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
    Féthière J; De Léan A
    Mol Pharmacol; 1991 Dec; 40(6):915-22. PubMed ID: 1684636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
    Mimeault M; Fournier A; Féthiere J; De Léan A
    Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rat renal preglomerular vessels, glomeruli and papillae do not express detectable quantities of B-type natriuretic peptide receptor.
    de Leon H; Bonhomme MC; Garcia R
    J Hypertens; 1994 May; 12(5):539-48. PubMed ID: 7930554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct properties of atrial natriuretic factor receptor subpopulations in epithelial and fibroblast cell lines.
    Féthière J; Meloche S; Nguyen TT; Ong H; De Lean A
    Mol Pharmacol; 1989 May; 35(5):584-92. PubMed ID: 2542756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontogeny of atrial natriuretic factor receptors and cyclic GMP response in rabbit renal glomeruli.
    Castro R; Leake RD; Ervin MG; Ross MG; Fisher DA
    Pediatr Res; 1991 Jul; 30(1):45-9. PubMed ID: 1653934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of the renal C-type natriuretic peptide receptor in hypertrophied and developing rat kidney.
    Woodard GE; Li X; Rosado JA
    J Mol Endocrinol; 2005 Dec; 35(3):519-30. PubMed ID: 16326837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic cleavage of atrial natriuretic factor receptor in bovine adrenal membranes by endogenous metalloendopeptidase. Effects on guanylate cyclase activity and ligand-binding specificity.
    Abe T; Misono KS
    Eur J Biochem; 1992 Oct; 209(2):717-24. PubMed ID: 1358609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of atrial and brain natriuretic peptides upon cyclic GMP levels, potassium transport, and receptor binding in rat astrocytes.
    Beaumont K; Tan PK
    J Neurosci Res; 1990 Feb; 25(2):256-62. PubMed ID: 2157033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
    Khurana ML; Pandey KN
    Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in binding sites for atrial natriuretic factor in kidneys and adrenal glands of Dahl hypertension-sensitive rats.
    Stewart RE; Swithers SE; McCarty R
    J Hypertens; 1987 Aug; 5(4):481-7. PubMed ID: 2822799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
    Cahill PA; Hassid A
    J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
    Thibault G; Grove KL; Deschepper CF
    Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characteristics of receptors for atrial natriuretic factor.
    Vandlen RL; Arcuri KE; Hupe L; Keegan ME; Napier MA
    Fed Proc; 1986 Aug; 45(9):2366-70. PubMed ID: 3015690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-bound guanylate cyclase as the receptor of natriuretic peptides. A minireview.
    Rambotti MG; Spreca A; Donato R
    Ital J Anat Embryol; 1995; 100 Suppl 1():55-62. PubMed ID: 11322335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
    Leitman DC; Murad F
    Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and characterization of natriuretic peptide receptors in the kidney of the toad, Bufo marinus.
    Meier SK; Toop T; Donald JA
    Gen Comp Endocrinol; 1999 Aug; 115(2):244-53. PubMed ID: 10417238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
    Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
    Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic factor alters neurotransmission independently of guanylate cyclase-coupled receptors in the rabbit vas deferens.
    Trachte GJ
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1227-33. PubMed ID: 8095549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of the solubilized atrial natriuretic factor receptor from bovine adrenal zona glomerulosa.
    Meloche S; Ong H; Cantin M; De Léan A
    Mol Pharmacol; 1986 Dec; 30(6):537-43. PubMed ID: 3023809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.
    Willenbrock RC; Tremblay J; Garcia R; Hamet P
    J Clin Invest; 1989 Feb; 83(2):482-9. PubMed ID: 2536399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.